Notice

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

Updates regarding government operating status and resumption of normal operations can be found at USA.gov.

Immune Tolerance Network (ITN)

Co-sponsored by NIAID and the Juvenile Diabetes Research Foundation International, the ITN is an international consortium of basic scientists and clinical investigators that performs clinical research to evaluate the safety and efficacy of methods that can induce the immune system to tolerate certain antigens for the treatment of immune-mediated disorders. Studies of immune tolerance in asthma and other allergic diseases are funded by the ITN.

Main Areas of Focus

  • To accelerate the clinical development of immune tolerance therapies
  • To develop, fund, and conduct clinical trials in immune tolerance
  • To test the safety and efficacy of methods that can induce the immune system to tolerate certain antigens for the treatment of immune-mediated disorders
  • To conduct studies of immune tolerance in autoimmune disease, asthma and other allergic diseases, organ transplantation, and type 1 diabetes
Content last reviewed on November 17, 2017